TitreEvaluation of the combination 5-fluorouracil, dacarbazine, and epirubicin in patients with advanced well-differentiated neuroendocrine tumors.
Publication TypeJournal Article
AuthorsWalter, T, Bruneton, D, Cassier, P-A, Hervieu, V, Pilleul, F, Scoazec, J-Y, Chayvialle, J-A, Lombard-Bohas, C
Full Text
Evaluation of the combination 5-fluorouracil, dacarbazine, and epirubicin in patients with advanced well-differentiated neuroendocrine tumors.